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Mendelian randomization is the use of genetic variants as in-
strumental variables to assess whether a risk factor is a cause of
a disease outcome. Increasingly, Mendelian randomization investiga-
tions are conducted on the basis of summarized data, rather than
individual-level data. These summarized data comprise the coeffi-
cients and standard errors from univariate regression models of the
risk factor on each genetic variant, and of the outcome on each genetic
variant. A causal estimate can be derived from these associations for
each individual genetic variant, and a combined estimate can be ob-
tained by inverse-variance weighted meta-analysis of these causal es-
timates. Various proposals have been made for how to calculate this
inverse-variance weighted estimate. In this paper, we show that the
inverse-variance weighted method as originally proposed (equivalent
to a two-stage least squares or allele score analysis using individual-
level data) can lead to over-rejection of the null, particularly when
there is heterogeneity between the causal estimates from different ge-
netic variants. Random-effects models should be routinely employed
to allow for this possible heterogeneity. Additionally, over-rejection
of the null is observed when associations with the risk factor and the
outcome are obtained in overlapping participants. The use of weights
including second-order terms from the delta method is recommended
in this case.
1. Introduction. Mendelian randomization is the use of genetic variants as in-
strumental variables to investigate the causal effect of a modifiable risk factor on
an outcome using observational data (Burgess and Thompson, 2015). Mendelian ran-
domization analyses are increasingly performed using summarized data, rather than
individual-level data (Burgess et al., 2015). There are various methods for combining
the estimates from multiple genetic variants into a single causal estimate (Burgess, Butterworth and Thompson
2013). In particular, an inverse-variance weighted method has been proposed (Johnson,
2013) that is equivalent (for a particular choice of weights) to the standard two-stage
least squares method usually employed with individual-level data (Burgess, Dudbridge and Thompson,
2015a). However, different authors have used different formulae for estimating the vari-
ances of the estimates that are used as weights (Dastani et al., 2012; Shen and Zhan,
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2015). Additionally, some authors have used fixed-effect meta-analysis for the combi-
nation of estimates from different genetic variants (Nelson et al., 2015), whereas other
authors have used random-effects meta-analysis (Ahmad et al., 2015).
In this paper, we compare the bias and coverage properties of estimates from the
inverse-variance weighted method for different choices of weights, and using fixed-
effect, additive random-effects, and multiplicative random-effects models for combin-
ing the estimates. In Section 2, we introduce the inverse-variance weighted method,
and demonstrate its equivalence to both a two-stage least squares analysis and to a
weighted linear regression of the association estimates. We also present the different
versions of the method that are investigated further in this paper. In Section 3, we
provide an example analysis that was the motivation for this work. In this example,
subtly different choices in the analysis method result in estimates that differ con-
siderably and lead to substantively different conclusions. In Section 4, we perform a
simulation study to compare the bias and coverage properties of the different versions
of the method. Finally, in Section 5, we discuss the findings of this paper and their
relevance to applied practice.
2. Methods. We provide a brief introduction to Mendelian randomization –
the use of genetic variants as instrumental variables; further introductory references
to the subject area are available (Davey Smith and Ebrahim, 2003; Lawlor et al.,
2008; Schatzkin et al., 2009). The objective of Mendelian randomization is to judge
whether intervention on a modifiable risk factor would affect a disease outcome. This
is achieved by testing whether genetic variants that satisfy the assumptions of an
instrumental variable for the risk factor are associated with the outcome. An instru-
mental variable is a variable that is associated with the risk factor, but not associated
with confounders of the risk factor–outcome association, nor is there any causal path-
way from the instrumental variable to the outcome except for that via the risk factor
(see Greenland (2000); Martens et al. (2006) for further information on instrumental
variables). This means that the genetic variant is an unconfounded proxy for varia-
tion in the risk factor, and therefore can be treated as similar to treatment assignment
in a randomized trial, where the treatment is to change the level of the risk factor
(Nitsch et al., 2006). Similarly to an intention-to-treat analysis in a randomized trial,
an association between such a genetic variant and the outcome implies a causal effect
of the risk factor (VanderWeele et al., 2014). Additionally, under further parametric
assumptions, the magnitude of the causal effect of the risk factor on the outcome can
be estimated (Didelez, Meng and Sheehan, 2010). In this paper, we assume that the
effect of the risk factor on the outcome is linear with no effect modification, and the
associations of the genetic variants with the risk factor and with the outcome are
linear without effect modification (Didelez and Sheehan, 2007):
E(X|Gj = g, U = u) = βX0j + βXj g + βXU u(1)
E(Y |Gj = g, U = u) = βY 0j + βY j g + βY U u for j = 1, . . . , J
E(Y |do(X = x), U = u) = β0 + β x+ βU u
where X is the risk factor, G1, . . . , GJ are the genetic variants, Y is the outcome, U is
an unmeasured confounder, do(X = x) is the do-operator of Pearl meaning that the
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value of the risk factor is set to x by intervention (Pearl, 2000), and the causal effect
parameter β =
βY j
βXj
for all j = 1, . . . , J . We also assume that the effects of the genetic
variants on the risk factor are the same in all individuals. Although these assumptions
are not necessary to identify a causal parameter (weaker assumptions have been pro-
posed (Swanson and Herna´n, 2013)), alternative assumptions mean that the causal
parameters identified by different instrumental variables are likely to be different.
While these assumptions are restrictive, a causal estimate has an interpretation as a
test statistic for the null hypothesis that the risk factor is not causal for the outcome
without requiring the assumptions of linearity and homogeneity of the genetic effects
on the risk factor (Burgess, Butterworth and Thompson, 2015).
We assume that summarized data are available in the form of association estimates
(beta-coefficients and standard errors) with the risk factor and with the outcome for
j = 1, . . . , J genetic variants that are instrumental variables. The association estimates
with the risk factor are denoted βˆXj with standard error σXj ; association estimates
with the outcome are denoted βˆY j with standard error σY j. The genetic variants are
assumed to be independently distributed (that is, not in linkage disequilibrium).
2.1. Standard inverse-variance weighted method. The ratio estimate of the causal
effect of the risk factor on the outcome based on the jth genetic variant is
βˆY j
βˆXj
(Lawlor et al., 2008). We refer to this as βˆIV j. The variance of the ratio of two random
variables can be calculated using the delta method; the formula including first- and
second-order terms for the variance of βˆIV j is:
(2) var(βˆIV j) =
σ2Y j
βˆ2Xj
+
βˆ2Y jσ
2
Xj
βˆ4Xj
−
2θβˆY jσY jσXj
βˆ3Xj
where θ is the correlation between βˆY j and βˆXj (Thomas, Lawlor and Thompson,
2007). This can be rewritten in terms of the causal estimates βˆIV j as:
(3) var(βˆIV j) =
1
βˆ2Xj
(
σ2Y j + βˆ
2
IV jσ
2
Xj − 2θβˆIV jσY jσXj
)
Assuming that the correlation between βˆY j and βˆXj is zero (this would be the case
if the associations with the risk factor and with the outcome were estimated in non-
overlapping datasets – known as a two-sample analysis (Pierce and Burgess, 2013)),
the variance is:
(4) var(βˆIV j) =
σ2Y j
βˆ2Xj
+
βˆ2Y jσ
2
Xj
βˆ4Xj
.
If only the first-order term from the delta formula is taken, then the variance is:
(5) var(βˆIV j) =
σ2Y j
βˆ2Xj
.
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The inverse-variance weighted (IVW) estimate is a weighted mean of the causal
estimates from each genetic variant considered individually:
(6) βˆIV W =
∑
j βˆIV j var(βˆIV j)
−1∑
j var(βˆIV j)
−1
.
This is equivalent to meta-analysing the causal estimates from each genetic variant us-
ing the standard inverse-variance weighted formula (hence the name “inverse-variance
weighted estimate”) under a fixed-effect model (Borenstein et al., 2009). Using the
first-order variance estimates (equation 5), the IVW estimate is:
(7) βˆIV W =
∑
j βˆY j βˆXjσ
−2
Y j∑
j βˆ
2
Xjσ
−2
Y j
.
This is the same estimate as would be obtained from a weighted linear regression of
the βˆY j coefficients on the βˆXj coefficients with no intercept term, using the σ
−2
Y j as
weights.
Using the first-order weights and assuming a fixed-effect model (Section 2.3), the
standard error is:
(8) se(βˆIV W ) =
√
1∑
j βˆ
2
Xjσ
−2
Y j
.
This is the form of the inverse-variance weighted estimate as it was initially proposed
(Johnson, 2013; Ehret et al., 2011; Dastani et al., 2012).
2.2. Equivalence to two-stage least squares estimate. The inverse-variance weighted
estimate using first-order weights is also equal to the estimate obtained from the two-
stage least squares method that is commonly used with individual-level data (sample
size N). If the we write the risk factor as X (usually an N×1 matrix, although the re-
sult can be generalized for multiple risk factors (Burgess, Dudbridge and Thompson,
2015a)), the outcome as Y (an N × 1 matrix), and the instrumental variables as
Z (an N × J matrix), then the two-stage least squares estimate of causal effects
(Baum, Schaffer and Stillman, 2003) is:
βˆ2SLS = [X
TZ(ZTZ)−1ZTX]−1XTZ(ZTZ)−1ZTY.
This estimate can be obtained by sequential regression of the risk factor on the in-
strumental variables, and then the outcome on fitted values of the risk factor from
the first-stage regression.
Regression of Y on Z gives beta-coefficients βˆY = (Z
TZ)−1ZTY with standard
errors the square roots of the diagonal elements of the matrix (ZTZ)−1σ2 where σ is
the residual standard error. If the instrumental variables are perfectly uncorrelated,
then the off-diagonal elements of (ZTZ)−1σ2 are all equal to zero. Regression of X
on Z gives beta-coefficients βˆX = (Z
TZ)−1ZTX. Weighted linear regression of the
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beta-coefficients βˆY on the beta-coefficients βˆX using the inverse-variance weights
(ZTZ)σ−2 gives an estimate:
[βˆTX(Z
TZ)βˆX ]
−1σ−2βˆTX(Z
TZ)σ2βˆY
=[XTZ(ZTZ)−1(ZTZ)(ZTZ)−1ZTX]−1XTZ(ZTZ)−1(ZTZ)(ZTZ)−1ZTY
=[XTZ(ZTZ)−1ZTX]−1XTZ(ZTZ)−1ZTY
=βˆ2SLS
The assumption of uncorrelated instrumental variables ensures that the regression
coefficients from univariate regressions (as in the regression-based methods) equal
those from multivariable regression (as in the two-stage least squares method). In
practice, the two-stage least squares and weighted regression-based estimates will
differ slightly as there will be non-zero correlations between the genetic variants in
finite samples, even if the variants are truly uncorrelated in the population. How-
ever, these differences are likely to be slight, and to tend to zero asymptotically
(Burgess, Dudbridge and Thompson, 2015b).
2.3. Fixed- versus random-effects. A fixed-effect meta-analysis assumes that the
causal effects targeted by each genetic variant are all equal. While this would be
true if all the genetic variants are valid instrumental variables, and also under the
additional linearity assumptions stated above, this may not be true in practice. For
instance, genetic variants may affect the exposure via different mechanisms, leading to
different magnitudes of effect on the outcome. Alternatively, some variants may have
direct effects on the outcome that do not pass via the risk factor, and hence not all
genetic variants may be valid instrumental variables. To combat heterogeneity in the
causal effects identified by each genetic variant, a random-effects meta-analysis may
be preferred. We outline two ways to model this heterogeneity: an additive random-
effects model, and a multiplicative random-effects model.
2.4. Additive and multiplicative random-effects models. In a fixed-effect meta-
analysis, we assume that the estimates from each instrumental variable βˆIV j can be
modelled as normally distributed with common mean βj = β and variance σ
2
IV j . In
a random-effects meta-analysis, the mean values βj are additionally assumed to vary
(Higgins, Thompson and Spiegelhalter, 2009). In an additive random-effects model,
the βj are assumed to be normally distributed with mean µβ and variance φ
2
A. Any
additional variability beyond that predicted by the fixed-effect model (φA > 0) is
interpreted as heterogeneity between the causal effects targeted by each instrumental
variable. An estimate of the heterogeneity parameter φˆA is often obtained by a method
of moments estimator, developed by DerSimonian and Laird (DerSimonian and Laird,
1986).
In a multiplicative random-effects model, the βˆIV j estimates are assumed to be
normally distributed with mean β and variance φ2Mσ
2
IV j . This model can be fitted by
linear regression of the βˆY j on the βˆXj using the σ
−2
Y j as weights. A fixed-effect model
can be fitted by setting the residual standard error in the regression model to be
one; this can be achieved after fitting the regression model by dividing the standard
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error by the estimate of the residual standard error (Thompson and Sharp, 1999). A
multiplicative random-effects model can be fitted by allowing the residual standard
error (which is equivalent to the heterogeneity parameter φM ) to be estimated as
part of the model. The multiplicative random-effects model is therefore equivalent to
an overdispersed regression model. In case of underdispersion (that is, the estimated
residual standard error is less than one), the standard errors should be fixed by set-
ting φˆM = 1, as any underdispersion is assumed to occur by chance, and not to be
empirically justified.
βˆIV j ∼ N (β, σ
2
IV j) (fixed-effect model)
βˆIV j ∼ N (βj , σ
2
IV j)
βj ∼ N (β, φ
2
A)
}
(additive random-effects model)
βˆIV j ∼ N (β, φ
2
Mσ
2
IV j) (multiplicative random-effects model)
The point estimate from a fixed-effect meta-analysis is identical to that from a
multiplicative random-effects meta-analysis (Thompson and Sharp, 1999). However,
it differs to that from an additive random-effects meta-analysis when φˆA 6= 0, as the
weights in the random-effects meta-analysis are inflated to account for heterogeneity.
As heterogeneity increases, weights become more similar, which results in estimates
with low weights being upweighted (relatively speaking) in an additive random-effects
meta-analysis.
2.5. Weak instrument bias. Although instrumental variable estimates are consis-
tent (and so they are asymptotically unbiased), they can suffer from substantial bias
in finite samples (Staiger and Stock, 1997; Stock, Wright and Yogo, 2002). This bias,
known as ‘weak instrument bias’, occurs when the instrumental variables explain a
small proportion of variance in the risk factor (Burgess and Thompson, 2011). In a
conventional Mendelian randomization analysis in which the risk factor and outcome
are measured in the same participants (a one-sample analysis), weak instrument bias
is in the direction of the observational association between the risk factor and the
outcome (Burgess, Thompson and CRP CHD Genetics Collaboration, 2011). It can
also lead to overly narrow confidence intervals and overrejection of the causal null
hypothesis (Stock and Yogo, 2002). Bias from the inverse-variance weighted method
using the first-order weights and a fixed-effect model has been shown to be simi-
lar to that from the two-stage least squares method in a realistic simulation study
(Burgess, Butterworth and Thompson, 2013). However, bias and coverage properties
have not been investigated for different choices of the weights or for random-effects
models.
3. Motivating example: analysis of the causal effect of early menopause
on triglycerides. This paper was motivated by a particular implementation of two
versions of the inverse-variance weighted method with different choices of weights
that gave substantially different answers. A Mendelian randomization analysis was
performed to assess the causal effect of early menopause risk on triglycerides using
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47 genetic variants. Associations of the genetic variants with early menopause (and
their standard errors) were obtained from Day et al. (2015); associations represent
number of years earlier menopause per additional effect allele. Associations of the
genetic variants with triglycerides (and their standard errors) were obtained from
the The Global Lipids Genetics Consortium (2013). These associations are provided
in Appendix Table A1 and displayed graphically in Appendix Figure A1. Analyses for
the motivating example were performed in Microsoft Excel (Windows 2000 version)
and R (version 3.1.2) (R Core Team, 2014).
Fixed-effect inverse-variance weighted methods were performed using the second-
order weights (equation 4) and the first-order weights (equation 5). The weights were
substantially the same in both cases; 35 out of the 47 weights differed by less than
5%, and 44 of the weights differed by less than 10%. Using the second-order weights
(equation 4), the causal effect of early menopause on triglycerides was estimated
as 0.0021 (standard error, 0.0037; 95% confidence interval: -0.0052, 0.0095). Using
the first-order weights (equation 5), the causal effect estimate was 0.0103 (standard
error, 0.0036; 95% confidence interval: 0.0032, 0.0175). These estimates represent the
change in triglycerides in standard deviation units per 1 year earlier menopause. The
applied implications of this analysis are not the focus of this paper, and depend on
the validity of the instrumental variable assumptions for the genetic variants used in
the analysis. However, the magnitude of the difference between the estimates (over
twice the standard error of the estimates) is striking, and the conclusions from the two
analyses would be diametrically opposite. In the first case, the causal null hypothesis
that early menopause is a causal risk factor for triglycerides would not be rejected
(p = 0.57), whereas in the second case, the causal null hypothesis would be rejected
(p = 0.005). By comparison, using the first-order weights and a multiplicative random
effects model, the standard error is 0.0103, meaning that the causal null hypothesis
would not be rejected (p = 0.32).
It turns out that the genetic variant with the greatest difference between the first-
and second-order weights is rs704795, the variant that also has the greatest causal
estimate. The estimate from this variant is heavily downweighted in the analysis
using the second-order weights compared with using the first-order weights. Omitting
this variant from the analysis led to similar estimates using the second- and first-
order weights (0.0000 versus −0.0001). Another interesting observation is that use
of the second-order weights reduced heterogeneity between the causal estimates from
each genetic variant (for example, in the multiplicative random-effects model, φˆM
was 1.69 using the second-order weights compared with 2.83 using the first-order
weights). This suggests that, even though the second-order standard errors for the
causal estimates from the individual variants will always be greater than the first-
order standard errors, precision of the overall causal estimate under a random-effects
model may be improved by using the second-order weights when there is heterogeneity
between the causal estimates (in this example, se(βˆIV W ) = 0.0063 in the multiplicative
random-effects model using the second-order weights, se(βˆIV W ) = 0.0103 using the
first-order weights).
Estimates from each of the methods are summarized in Table 1.
In general, genetic variants that have large values of βˆY j and/or small values of
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Fig 1. Graph of second-order weights against first-order weights for motivating example.
.
Method Estimate Standard error 95% confidence interval Heterogeneity (φˆ)
Fixed-effects model, second-
order weights
0.0021 0.0037 -0.0052, 0.0095 -
Fixed-effects model, first-
order weights
0.0103 0.0036 0.0032, 0.0175 -
Additive random-effects
model, second-order weights
0.0057 0.0070 -0.0080, 0.0193 0.036
Additive random-effects
model, first-order weights
0.0104 0.0109 -0.0110, 0.0317 0.068
Multiplicative random-effects
model, second-order weights
0.0021 0.0063 -0.0103, 0.0145 1.686
Multiplicative random-effects
model, first-order weights
0.0103 0.0103 -0.0099, 0.0305 2.826
Table 1
Results from motivating example: estimates of causal effect of early menopause on triglycerides
(standard deviation increase in triglycerides per one year earlier menopause) using different
inverse-variance weighted methods.
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βˆXj will be downweighted by the second-order weights. This means that genetic vari-
ants that have large and heterogeneous effects on the outcome compared with other
variants and/or are weak will be downweighted. Further methodological investigation
is therefore needed to investigate the impact on the bias and coverage properties of
inverse-variance weighted methods for Mendelian randomization analyses, and which
of the versions of the method should be preferred in applied practice.
4. Simulation study. In this manuscript, we consider estimates from the inverse-
variance weighted method using weights from equations (4, second-order) and (5, first-
order), and fixed-effect, additive random-effects, and multiplicative random-effects
models for combining the estimates from different genetic variants. Code for imple-
menting these methods is provided in the Appendix. Analyses for the simulation study
were performed in R (version 3.1.2).
The data-generating model is as follows:
zij ∼ Binomial(2, 1/3) independently for j = 1, . . . , 20(9)
xi =
20∑
j=1
αjzij + ui + ǫXi
yi = βXxi +
20∑
j=1
βZjzij + βUui + ǫY i
ui, ǫXi, ǫY i ∼ N (0, 1) independently
αj ∼ N (α, 0.02
2) independently.
Individuals are indexed by i. The 20 genetic variants zij, indexed by j, are drawn from
binomial distributions, corresponding to single nucleotide polymorphisms (SNPs) with
minor allele frequency 1/3. The risk factor xi is a linear combination of the genetic
variants, a confounder (ui) that is assumed to be unmeasured, and an independent
error term (ǫXi). The risk factor yi is a linear combination of the genetic variants,
the risk factor, confounder, and a further independent error term (ǫY i). The per
allele effects of the genetic variants on the risk factor (αj) are drawn from a normal
distribution with mean α and variance 0.022. The direct effects of the genetic variants
on the outcome (βZj , these effects are not via the risk factor) are zero when the genetic
variants are valid instrumental variables. The causal effect of the risk factor on the
outcome, the main parameter of interest, is βX . The effect of the confounder on the
outcome is βU .
We consider four scenarios:
1. a one-sample analysis in which the genetic variants are all valid instrumental
variables;
2. a one-sample analysis in which the genetic variants have direct effects on the
outcome;
3. a two-sample analysis in which the genetic variants are all valid instrumental
variables;
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4. and a two-sample analysis in which the genetic variants have direct effects on
the outcome.
In scenarios 1 and 2, data are generated for N = 5000 participants, and associations
with the risk factor and with the outcome are estimated in these participants. In
scenarios 3 and 4, data are generated for N = 10000 participants. Associations with
the risk factor are estimated in the first 5000 participants, and associations with
the outcome in the second 5000 participants. Two-sample analyses are common in
Mendelian randomization, particularly when the association estimates are obtained
from publicly available data sources (Burgess et al., 2015). In a two-sample analysis,
weak instrument bias acts in the direction of the null, and hence should not lead to
misleading inferences (Pierce and Burgess, 2013). However, it is common that many
participants in large genetic consortia overlap, such that even if the associations with
the risk factor and with the outcome are obtained from separate consortia, they may
not be estimated in separate participants. Hence, the one-sample and two-sample
settings are both of interest in this paper.
In scenarios 1 and 3, the βZj parameters are all set to zero, and the genetic vari-
ants are all valid instrumental variables. In scenarios 2 and 4, the βZj parameters
are drawn from a normal distribution with mean 0 and variance 0.022. This is a
situation known as “balanced pleiotropy” (Bowden et al., 2015). Pleiotropy refers to
a genetic variant having an independent effect on the outcome that is not via the
risk factor (Davey Smith and Hemani, 2014). Balanced pleiotropy means that the
pleiotropic effects for all strengths of instrument have mean zero. Such pleiotropic
effects should induce heterogeneity between the causal estimates using different ge-
netic variants. Simulations conducted under a multiplicative random-effects model
with balanced pleiotropy have suggested that estimates may not be biased on aver-
age (Bowden, Davey Smith and Burgess, 2015). Additional simulations for the case
of directional (that is, unbalanced) pleiotropy are considered in the Appendix.
Four sets of parameters are considered – two values of the causal effect: βX = 0 (null
causal effect), and βX = 0.2 (positive causal effect); and two values of the confounder
effect: βU = +1 (positive confounding), and βU = −1 (negative confounding). Addi-
tionally, four values of instrument strength are considered for each set of parameters:
α = 0.03, 0.05, 0.08, 0.10. 10 000 simulated datasets are generated in each case.
4.1. Results. Scenarios 1 and 2: Results from scenario 1 (one-sample, valid in-
struments) and scenario 2 (one-sample, invalid instruments) are presented in Table 2.
For each value of the instrument strength, set of parameters, and scenario, the mean
estimate and empirical power of the 95% confidence interval (estimate plus or minus
1.96 times the standard error) to reject the null hypothesis is given. The coverage is
100% minus the power; power under the null hypothesis should be 5%. The Monte
Carlo standard error for the mean estimate is around 0.001 or less, and for the power
is 0.2% under the null, and at most 0.5% otherwise. Additionally, to judge the instru-
ment strength, the mean F statistic and the mean coefficient of determination (R2
statistic) are given in each case.
With a null causal effect, the results demonstrate the well-known bias and in-
flated Type 1 error rate of instrumental variable estimates with weak instruments in
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a one-sample setting. Although bias is similar for both choices of weights (slightly
less with the first-order weights), coverage rates are much worse with the first-order
weights. Neither the additive nor the multiplicative random-effects models detect het-
erogeneity in the vast majority of cases (particularly for weaker instruments) with
the second-order weights. With the first-order weights, heterogeneity is detected in a
greater proportion of simulated datasets. In scenario 1, heterogeneity is not present
in the underlying data-generating model, and only estimated by chance; in scenario
2, heterogeneity is expected. For the second-order weights, coverage properties are
similar in scenarios 1 and 2; whereas for the first-order weights, coverage properties
are worse in scenario 2 for the fixed-effect model, but improved for the random-effects
models. For weaker instruments, coverage properties are best using the second-order
weights, whereas for stronger instruments, estimates using the first-order weights and
a random-effects model perform almost as well, and occasionally better particularly
when there is heterogeneity (scenario 2). However, there is inflation of Type 1 error
rates even in the best-case scenarios.
With a positive causal effect, estimates with the first-order weights generally have
better power to detect a causal effect than those using the second-order weights,
particularly with weaker instruments. However, in the light of the Type 1 error rate
inflation, this property should not be overvalued. Making fewer Type 2 errors (fewer
false negative findings) at the expense of making more Type 1 errors (more false
positive findings) is not generally a desirable trade-off.
Additional results from scenarios 1 and 2 are presented in Appendix Table A3. For
each value of the instrument strength, the (Monte Carlo) standard deviation and the
mean standard error of estimates are presented. This helps judge whether uncertainty
in the effect estimates is correctly accounted for in the standard errors.
The estimates using second-order weights are the least variable throughout, with the
lowest standard deviations. The standard deviation of estimates using second-order
weights was always less than the mean standard error of the estimates. In contrast, for
scenario 1, the estimates using first-order weights were more variable, but generally
had lower average standard errors. This was always true for the fixed-effect analyses,
and usually true for the random-effects analyses. However, when there was hetero-
geneity in the causal estimates identified by the instrumental variables (scenario 2),
mean standard errors for the random-effects analyses using first-order weights could
be greater than those using second-order weights, despite the second-order standard
errors for each causal estimate being uniformly than the first-order standard errors. In
scenario 2, mean standard errors for the fixed-effect analyses were generally similar to
those in scenario 1, but the standard deviations of the estimates were increased. For
the random-effects analyses using the first-order weights in scenario 2, mean standard
errors and standard deviations were similar in magnitude. However, mean standard
errors using the second-order weights were typically slightly lower, with no loss in
coverage (recall Table 2).
Under the null, standard deviations and mean standard errors are similar whether
there is positive or negative confounding, whereas under the alternative, standard
errors appear to be wider when confounding is in the same direction as the causal
effect, and narrower when confounding is in the opposite direction. This has previously
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been observed (Burgess and Thompson, 2012); see Figure 3 of that reference for a
potential explanation.
Scenarios 3 and 4: Results from scenario 3 (two-sample, valid instruments) and
scenario 4 (two-sample, invalid instruments) are presented in Table 3 for the mean
and power and in Appendix Table A4 for the standard deviation and standard error.
These results demonstrate the well-known bias in the direction of the null in the
two-sample setting.
With a null causal effect, no bias is observed. Coverage levels for the second-order
weights are conservative, with power below the nominal 5% level. By contrast, in
scenario 3, coverage levels with the first-order weights are close to nominal levels,
with slight undercoverage for random-effects models. In scenario 4, there is inflation
of Type 1 error rates with the first-order weights for a fixed-effect model, but coverage
for both the additive and multiplicative random-effects models is close to nominal
levels.
With a positive causal effect, bias is in the direction of the null. The bias is more
severe using the second-order weights. Power to detect a causal effect is substantially
lower using the second-order weights than using the first-order weights, particularly
for weaker instruments.
For the first-order weights, mean standard errors are fairly close to the standard
deviations of estimates for the fixed-effect model when there is no heterogeneity in
the causal effects, and for the random-effects models when there is heterogeneity
in the causal effects. In contrast, for the second-order weights, the mean standard
errors are larger than the standard deviations throughout. This corresponds with
the coverage properties: in a two-sample setting using first-order weights, estimates
are unbiased under the null with correct rejection rates, whereas using second-order
weights, rejection rates are conservative.
Choice of random-effects model: As for choosing between the additive and mul-
tiplicative random-effects models, with the second-order weights, there was little dif-
ference between the results, or even with the results for a fixed-effect model. However,
as viewed in the motivating example, there will be a difference if the level of het-
erogeneity is increased. With the first-order weights, bias was generally slightly less
with the additive random-effect model. Coverage under the null was better with an
additive random-effects model, and power to detect a causal effect was better with a
multiplicative random-effects model. However, differences were slight. Because of the
better properties under the null, we therefore prefer the additive random-effects model
for the scenarios considered in this paper, although the preference is not a strong one.
Directional pleiotropy: Results with directional pleiotropy are presented in Ap-
pendix Table A5. In brief, the results echo those with no pleiotropy and with balanced
pleiotropy: the importance of random-effects models, and the preference for use of
second-order weights in a one-sample setting, and first-order weights in a two-sample
setting.
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Fixed-effect Additive random-effects Multiplicative random-effects
Second-order First-order Second-order First-order Second-order First-order
α F R2 Mean Power Mean Power Mean Power Mean Power Mean Power Mean Power
Scenario 1. One-sample setting, valid instrumental variables
1a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.166 11.4 0.200 28.5 0.166 11.4 0.196 24.3 0.166 11.4 0.200 26.2
0.05 4.2 1.7% 0.111 9.9 0.118 18.3 0.111 9.9 0.110 14.6 0.111 9.9 0.118 16.3
0.08 8.6 3.3% 0.058 8.1 0.052 11.1 0.057 8.0 0.044 8.5 0.058 8.0 0.052 9.6
0.10 12.5 4.8% 0.041 7.2 0.036 9.4 0.040 7.0 0.029 7.3 0.041 7.2 0.036 8.1
1b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% -0.170 11.2 -0.207 29.1 -0.170 11.2 -0.204 25.2 -0.170 11.2 -0.207 27.1
0.05 4.2 1.7% -0.108 9.3 -0.113 17.7 -0.107 9.3 -0.105 14.3 -0.108 9.3 -0.113 16.0
0.08 8.6 3.3% -0.059 8.2 -0.054 11.2 -0.059 8.1 -0.046 8.5 -0.059 8.2 -0.054 9.7
0.10 12.5 4.8% -0.041 7.1 -0.036 9.4 -0.040 6.8 -0.029 7.2 -0.041 6.9 -0.036 7.8
1c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.337 44.8 0.403 71.9 0.337 44.8 0.402 70.1 0.337 44.8 0.403 71.2
0.05 4.2 1.7% 0.284 58.3 0.318 74.1 0.284 58.3 0.315 71.5 0.284 58.3 0.318 73.2
0.08 8.6 3.3% 0.241 79.5 0.257 85.4 0.241 79.4 0.254 82.5 0.241 79.5 0.257 84.5
0.10 12.5 4.8% 0.222 89.6 0.234 92.4 0.222 89.5 0.231 90.5 0.222 89.6 0.234 91.7
1d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% -0.006 0.8 0.000 5.1 -0.006 0.8 0.006 3.4 -0.006 0.8 0.000 3.8
0.05 4.2 1.7% 0.061 4.3 0.092 15.6 0.061 4.3 0.106 12.7 0.061 4.3 0.092 12.2
0.08 8.6 3.3% 0.114 29.7 0.146 53.1 0.114 29.7 0.160 49.6 0.114 29.6 0.146 45.7
0.10 12.5 4.8% 0.132 56.4 0.160 75.6 0.134 56.2 0.172 73.2 0.132 55.5 0.160 68.1
Scenario 2. One-sample setting, invalid instrumental variables
2a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.159 11.6 0.201 32.1 0.159 11.6 0.191 19.1 0.159 11.6 0.201 23.9
0.05 4.2 1.7% 0.105 11.8 0.113 22.8 0.104 11.7 0.090 11.6 0.105 11.7 0.113 15.6
0.08 8.6 3.3% 0.062 10.9 0.057 16.6 0.060 9.9 0.035 7.8 0.062 10.2 0.057 10.3
0.10 12.5 4.8% 0.044 10.3 0.038 14.6 0.040 8.4 0.020 7.2 0.044 9.1 0.038 8.8
2b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% -0.157 11.9 -0.198 31.3 -0.157 11.9 -0.187 18.0 -0.157 11.9 -0.198 22.9
0.05 4.2 1.7% -0.102 11.7 -0.109 22.7 -0.101 11.6 -0.085 11.7 -0.102 11.7 -0.109 15.4
0.08 8.6 3.3% -0.060 11.1 -0.055 16.6 -0.058 9.7 -0.032 7.9 -0.060 10.4 -0.055 10.6
0.10 12.5 4.8% -0.044 9.7 -0.038 14.6 -0.040 7.7 -0.020 7.3 -0.044 8.5 -0.038 8.9
2c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.317 39.2 0.400 68.8 0.317 39.2 0.393 56.9 0.317 39.2 0.400 63.0
0.05 4.2 1.7% 0.270 53.4 0.313 71.2 0.270 53.4 0.299 57.8 0.270 53.4 0.313 65.2
0.08 8.6 3.3% 0.234 72.3 0.257 81.1 0.234 71.4 0.243 68.3 0.234 71.9 0.257 75.3
0.10 12.5 4.8% 0.221 83.8 0.238 88.1 0.219 82.1 0.227 78.0 0.221 83.0 0.238 84.3
2d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% -0.008 2.2 -0.001 11.8 -0.008 2.2 0.013 4.8 -0.008 2.2 -0.001 5.8
0.05 4.2 1.7% 0.051 5.2 0.086 19.6 0.051 5.1 0.116 11.0 0.051 5.1 0.086 10.5
0.08 8.6 3.3% 0.106 29.1 0.146 53.3 0.112 27.9 0.175 43.7 0.106 27.3 0.146 36.5
0.10 12.5 4.8% 0.133 59.0 0.166 77.4 0.141 56.5 0.189 69.5 0.133 52.8 0.166 61.8
Table 2
Simulation study results for scenarios 1 and 2 (one-sample setting, valid and invalid
instrumental variables): mean estimate and power (%) of 95% confidence interval for
various inverse-variance weighted methods with four sets of parameter values (null and
positive causal effect, positive and negative confounding. The strength of the genetic variants
as instruments is indicated: mean per allele effect on the risk factor (α), mean F statistic
(F ) and mean coefficient of determination (R2) from regression of risk factor on the genetic
variants.
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Fixed-effect Additive random-effects Multiplicative random-effects
Second-order First-order Second-order First-order Second-order First-order
α F R2 Mean Power Mean Power Mean Power Mean Power Mean Power Mean Power
Scenario 3. Two-sample setting, valid instrumental variables
3a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.001 0.8 0.002 5.1 0.001 0.8 0.002 3.7 0.001 0.8 0.002 4.2
0.05 4.2 1.7% 0.001 1.2 0.001 4.8 0.001 1.2 0.001 3.6 0.001 1.2 0.001 3.9
0.08 8.6 3.3% 0.001 2.0 0.001 4.9 0.001 2.0 0.001 3.8 0.001 2.0 0.001 3.9
0.10 12.5 4.8% -0.001 2.1 -0.001 4.6 -0.001 2.0 -0.001 3.6 -0.001 2.0 -0.001 3.8
3b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% -0.001 0.8 -0.001 4.9 -0.001 0.8 -0.001 3.5 -0.001 0.8 -0.001 4.0
0.05 4.2 1.7% 0.001 1.2 0.001 4.6 0.001 1.2 0.001 3.5 0.001 1.2 0.001 3.8
0.08 8.6 3.3% -0.001 1.9 -0.001 4.8 -0.001 1.9 -0.001 3.7 -0.001 1.9 -0.001 4.0
0.10 12.5 4.8% 0.000 2.4 0.000 4.8 0.000 2.4 0.000 3.8 0.000 2.4 0.000 3.9
3c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.090 2.4 0.119 11.5 0.090 2.4 0.121 8.8 0.090 2.4 0.119 9.7
0.05 4.2 1.7% 0.126 10.2 0.162 26.1 0.126 10.2 0.166 22.0 0.126 10.2 0.162 22.6
0.08 8.6 3.3% 0.153 35.5 0.182 54.1 0.153 35.2 0.186 48.8 0.153 35.3 0.182 48.9
0.10 12.5 4.8% 0.162 61.8 0.184 74.7 0.162 61.2 0.188 70.7 0.162 61.1 0.184 70.5
3d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% 0.091 3.7 0.120 15.7 0.091 3.7 0.123 12.2 0.091 3.7 0.120 13.1
0.05 4.2 1.7% 0.121 14.4 0.154 32.9 0.121 14.4 0.159 27.6 0.121 14.4 0.154 28.7
0.08 8.6 3.3% 0.152 52.0 0.181 71.6 0.152 51.8 0.185 66.8 0.152 51.7 0.181 66.8
0.10 12.5 4.8% 0.159 77.6 0.182 87.8 0.160 77.1 0.185 85.0 0.159 76.9 0.182 84.5
Scenario 4. Two-sample setting, invalid instrumental variables
4a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.001 2.2 0.001 10.4 0.001 2.2 0.002 4.8 0.001 2.2 0.001 6.0
0.05 4.2 1.7% 0.000 2.4 0.000 9.8 0.000 2.3 0.000 4.4 0.000 2.4 0.000 5.1
0.08 8.6 3.3% 0.000 4.4 0.000 10.2 0.000 4.0 0.000 5.3 0.000 4.2 0.000 5.9
0.10 12.5 4.8% 0.001 5.3 0.001 10.1 0.001 4.3 0.001 5.3 0.001 4.5 0.001 5.8
4b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% 0.004 1.7 0.005 10.6 0.004 1.7 0.005 4.8 0.004 1.7 0.005 6.1
0.05 4.2 1.7% 0.000 3.1 -0.001 10.1 0.000 3.1 0.000 4.9 0.000 3.1 -0.001 5.7
0.08 8.6 3.3% -0.001 4.0 -0.001 9.4 -0.001 3.7 -0.001 5.0 -0.001 3.7 -0.001 5.4
0.10 12.5 4.8% 0.000 5.4 0.000 10.9 0.000 4.6 0.000 6.0 0.000 4.7 0.000 6.2
4c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.086 3.9 0.120 16.0 0.086 3.9 0.125 8.9 0.086 3.9 0.120 10.6
0.05 4.2 1.7% 0.115 10.2 0.154 27.6 0.115 10.1 0.163 17.5 0.115 10.1 0.154 19.1
0.08 8.6 3.3% 0.145 34.2 0.178 54.4 0.146 33.2 0.187 42.4 0.145 33.3 0.178 42.7
0.10 12.5 4.8% 0.156 56.4 0.183 71.8 0.159 53.2 0.191 61.0 0.156 52.6 0.183 60.4
4d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% 0.084 5.3 0.120 21.2 0.085 5.3 0.126 10.4 0.084 5.3 0.120 12.2
0.05 4.2 1.7% 0.112 14.7 0.153 36.3 0.112 14.5 0.164 21.7 0.112 14.6 0.153 23.6
0.08 8.6 3.3% 0.138 46.7 0.172 66.4 0.140 44.4 0.182 52.0 0.138 44.2 0.172 52.3
0.10 12.5 4.8% 0.154 70.3 0.183 83.7 0.158 66.1 0.191 72.3 0.154 65.3 0.183 71.5
Table 3
Simulation study results for scenarios 3 and 4 (two-sample setting, valid and invalid
instrumental variables): mean estimate and power (%) of 95% confidence interval for
various inverse-variance weighted methods with four sets of parameter values (null and
positive causal effect, positive and negative confounding. The strength of the genetic variants
as instruments is indicated: mean per allele effect on the risk factor (α), mean F statistic
(F ) and mean coefficient of determination (R2) from regression of risk factor on the genetic
variants.
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4.2. Additional scenario: extreme outlying variants. In the motivating example,
the difference between estimates seemed to be driven by a single rogue variant. In
order to better evaluate bias and coverage in this scenario, we considered an addi-
tional simulation scenario 5. Rather than generating the direct effects of the genetic
variants on the outcome (the βZj parameters) from a normal distribution with mean
0 and variance 0.022, instead we generated them from a t distribution with 2 degrees
of freedom, and multiplied the result by 0.02. The t distribution with a small num-
ber of degrees of freedom has much heavier tails than a normal distribution, and so
extreme outliers will be more frequent. With 2 degrees of freedom, the variance of
the t distribution is not even defined. Simulation results are only considered in the
one-sample setting and under the null (βX = 0), as inflated Type 1 error rates in this
scenario are the primary concern.
In Table 4, results are given for the inverse-variance weighted methods with different
choices of weights and different models for combining the estimates. With a fixed-effect
model, coverage rates for the second-order weights are similar to those in scenario 2
with the normally distributed direct effects. For the first-order weights, coverage rates
are substantially worse and well above the nominal 5% level even for the strongest
instruments considered in this paper, although bias is similar to that in scenario 2.
This corresponds to the motivating example, in which the outlying variant had a
large influence on the pooled estimate using the first-order weights, but was heavily
downweighted using the second-order weights. However, for a random-effects model
using the second-order weights, particularly with the multiplicative random-effects
model and for the additive random-effects model with weaker instruments, results
were similar to those with a fixed-effect model. In contrast, for a random-effects model
with the first-order weights, mean estimates were generally closer to the null (with
one notable exception – scenario 5b, α = 0.05 – that was mostly driven by a single
aberrant estimate) and coverage levels were much improved. Coverage levels with a
random-effects model were generally slightly better with the first-order weights than
with the second-order weights, although not uniformly and the difference was slight.
As observed in the motivating example, and particularly with weaker instruments,
heterogeneity is more often detected using the first-order weights, as the second-order
weights tend to downweight the influence of the outlying variants.
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Fixed-effect Additive random-effects Multiplicative random-effects
Second-order First-order Second-order First-order Second-order First-order
α F R2 Mean Power Mean Power Mean Power Mean Power Mean Power Mean Power
Scenario 5. One-sample setting, invalid instrumental variables with extreme outliers
5a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.149 12.5 0.200 40.7 0.149 12.3 0.208 13.2 0.149 12.4 0.200 16.6
0.05 4.2 1.7% 0.105 13.1 0.106 35.3 0.103 12.2 0.078 9.0 0.105 12.5 0.106 12.4
0.08 8.6 3.3% 0.058 13.9 0.053 31.9 0.050 8.9 0.005 7.4 0.058 10.2 0.053 8.9
0.10 12.5 4.8% 0.042 14.0 0.035 30.6 0.030 6.9 -0.004 6.8 0.042 8.1 0.035 7.6
5b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% -0.153 12.8 -0.209 41.4 -0.152 12.6 -0.178 13.7 -0.153 12.7 -0.209 16.6
0.05 4.2 1.7% -0.101 13.8 -0.094 36.0 -0.100 12.4 -0.232 8.6 -0.101 12.9 -0.094 11.5
0.08 8.6 3.3% -0.058 13.4 -0.067 32.6 -0.050 8.4 -0.005 7.0 -0.058 10.0 -0.067 8.9
0.10 12.5 4.8% -0.043 13.9 -0.047 30.2 -0.032 7.2 0.001 6.4 -0.043 8.6 -0.047 7.9
Table 4
Simulation study results for scenarios 5 (one-sample setting, invalid instrumental variables
with extreme outliers): mean estimate and power (%) of 95% confidence interval for various
inverse-variance weighted methods with two sets of parameter values (null causal effect,
positive and negative confounding. The strength of the genetic variants as instruments is
indicated: mean per allele effect on the risk factor (α), mean F statistic (F ) and mean
coefficient of determination (R2) from regression of risk factor on the genetic variants.
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5. Discussion. Several high-profile Mendelian randomization analyses have em-
ployed summarized data and some version of an inverse-variance weighted method.
These include analyses of the causal effect of blood pressure on coronary heart disease
risk (Ehret et al., 2011), height on coronary heart disease risk (Nelson et al., 2015),
adiponectin on type 2 diabetes risk (Dastani et al., 2012), lipids on type 2 diabetes
risk (Fall et al., 2015), and telomere length on risk of various cancers (Zhang et al.,
2015), amongst several others. The statistical properties of estimates from the inverse-
variance weighted method are therefore of considerable interest.
In this paper, we demonstrated that Type 1 error rates for the inverse-variance
weighted method as it was initially proposed (first-order weights, fixed-effect model)
are likely to be inflated in a one-sample Mendelian randomization setting either when
the instruments are weak, or when there is heterogeneity between the causal estimates
targeted by different genetic variants. This can be resolved either by using second-
order weights or a random-effects model to combine the estimates from multiple ge-
netic variants. These approaches affect the analysis in different ways: the second-order
weights tend to downweight the influence of weak and heterogeneous variants on the
overall causal estimate, whereas the random-effects models tend to increase standard
errors by allowing for heterogeneity between the causal estimates in the model. While
both approaches can be applied simultaneously, our simulations indicate that het-
erogeneity is less substantial when using the second-order weights. However, there is
little disadvantage in assuming a random-effects model, as in the absence of hetero-
geneity, the fixed-effect analysis is recovered, and in the presence of heterogeneity, the
random-effects analysis is more appropriate. Our results provide slight preference for
an additive random-effects model over a multiplicative random-effects model.
In a two-sample Mendelian randomization setting, weak instruments do not lead
to inflated Type 1 error rates but rather attenuate of estimates towards the null.
The use of second-order weights was demonstrated to lead to conservative inference,
whereas first-order weights gave correct coverage rates under the null. When there
was heterogeneity in the causal estimates from different genetic variants, which was
simulated to arise due to genetic variants having pleiotropic effects, a fixed-effect
model with first-order weights was shown to lead to undercoverage, although this was
corrected by use of a random-effects model.
A conclusion from this paper is the need to assess heterogeneity between the causal
estimates from different genetic variants prior to performing a Mendelian randomiza-
tion analysis based on multiple genetic variants, for example by a scatter plot of the
gene–risk factor and gene–outcome associations (Appendix Figure A1). The presence
of heterogeneous variants is likely to indicate violation of the instrumental variable
assumptions for some of the variants, and can lead to misleading estimates as ob-
served in the motivating example. Assessment for heterogeneity is also relevant when
performing an analysis using individual-level data, for example using a two-stage least
squares or allele score method.
5.1. Limitation of simulation studies. Our conclusions are limited as they are
based on simulation studies. This is by necessity, as the properties of the estima-
tors that we want to assess are finite-sample properties, not asymptotic properties.
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Our findings may have differed if we had considered a different data-generating mech-
anism, or more substantial heterogeneity between estimates from genetic variants.
However, the findings are in line with theoretical considerations, and we believe the
scenarios that we have chosen to be representative of a typical Mendelian randomiza-
tion investigation in practice.
5.2. Unbalanced pleiotropy and robust methods (Egger regression, median-based ap-
proaches). In particular, we mostly considered scenarios in this paper corresponding
to balanced pleiotropy. In the case of unbalanced (or directional) pleiotropy, causal
estimates from inverse-variance weighted methods are biased and Type 1 error rates
are inflated in all settings, even in the asymptotic limit (Bowden et al., 2015). This
can be resolved in a number of ways. In Egger regression, we perform a weighted
linear regression of the gene–outcome association estimates (βˆY j) on the gene–risk
factor association estimates (βˆXj) in the same way as in an inverse-variance weighted
method, except that an intercept term is included in the regression model. This inter-
cept term represents the average direct effect of the genetic variants on the outcome.
(It is additionally required that all genetic variants are orientated such that the βˆXj
estimates are all positive, or are all negative.) The causal estimate from Egger regres-
sion is the slope parameter from this regression model. It is a consistent estimate of
the causal effect under the alternative assumption that the direct effects of the genetic
variants are uncorrelated with the instrument strength; this is known as the InSIDE
(instrument strength independent of direct effect) assumption. In the notation of the
data-generating model of equation (9), the αj parameters must be uncorrelated with
the βZj parameters; in the balanced pleiotropy examples of this paper, these param-
eters are drawn from independent distributions. This is a weaker assumption than
the standard instrumental variable assumptions (the βZj parameters all equal zero)
or the assumption of balanced pleiotropy (the βZj parameters have mean zero).
Similar considerations as to the choice of weights in Egger regression could be con-
sidered; the original proposal was equivalent to using the first-order weights. Informal
simulations (not presented) have suggested that the same conclusions from this paper
also hold for Egger regression (particularly the use of random-effects models). How-
ever, a full investigation would require simulating data with unbalanced pleiotropy
(potentially both when the InSIDE assumption is satisfied and when it is violated);
this is considered to be beyond the scope of this paper.
One notable difference about Egger regression is that if the genetic variants are
allowed to have direct effects on the outcome, then heterogeneity in the causal es-
timates from individual variants is expected. Therefore, while heterogeneity in an
inverse-variance weighted analysis is unwelcome and a potential sign that the assump-
tions are not satisfied, heterogeneity in the Egger method is a natural consequence of
weakening the instrumental variable assumptions and does not necessarily invalidate
the analysis.
Another approach for dealing with unbalanced pleiotropy is a median-based ap-
proach. The median of the causal estimates from each of the genetic variants taken
individually is a consistent estimate of the causal effect under the assumption that at
least 50% of the genetic variants are valid instrumental variables (Han, 2008). This
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is a different assumption to the InSIDE assumption, and neither assumption includes
all cases of the other. Confidence intervals for the median can be obtained by boot-
strapping; we suggest estimating a bootstrap standard error and forming confidence
intervals from the standard error (Bowden et al., 2015). A weighted median estima-
tor can also be obtained using inverse-variance weights in a weighted median function
(Bowden et al., 2015). This method may have better asymptotic properties than an
inverse-variance weighted method in a number of cases, as outlying estimates do not
influence the median of the distribution. Simulations performed using second- and
first-order weights from the delta method suggested that weighted median estimates
were not sensitive to the particular choice of weighting function. In a median-based
approach, the choice of weights influences not only the bias and variability of esti-
mates, but also the identification condition, as the consistency criterion for a weighted
median estimator is that 50% of the weight in the analysis corresponds to valid in-
strumental variables. Hence, in some cases, the simple (unweighted) median estimator
may be preferred even if it is less efficient.
5.3. Overlap between the samples in a ‘two-sample’ analysis. In practice, before
following the recommendation to use first-order weights in a two-sample Mendelian
randomization setting, it is advisable to check whether the samples used to estimate
the gene–risk factor and the gene–outcome associations truly do not overlap. In the
motivating example of the paper, genetic associations with early menopause are ob-
tained from a consortium of 33 studies, and genetic associations with triglycerides
from a consortium of 23 studies. Although the consortia appear to be different, in
fact, at least 17 of the studies are included in both consortia, meaning that the anal-
ysis is not a true two-sample analysis. It is not clear exactly the extent of the overlap
without having the individual-level data, but it is likely to be substantial.
Although the full second-order expression for the variance of a causal estimate
(equation 2) includes a term θ that depends on the overlap between the two datasets,
in this paper we have set θ = 0 even in a one-sample setting. This was undertaken for
computational simplicity in the simulation study setting. If the individual-level data
were available, an estimate of θ could be obtained by bootstrapping the samples, and
calculating the correlation between the bootstrapped distributions of βˆY j and βˆXj
for each j. However, this was infeasible in the simulation study. Additionally, if the
individual-level data are not available, it is unclear how to estimate θ. A sensitivity
analysis can be performed for the value of θ; results for the motivating example of
this paper are shown in Appendix Table A2. We see that different choices of θ lead to
similar causal estimates and 95% confidence intervals for each of the inverse-variance
weighted methods.
5.4. Interpretation of a random-effects estimate. A theoretical concern in recom-
mending the use of random-effects models for Mendelian randomization is the inter-
pretation of the random-effects estimate. Under the assumptions of linearity and no
effect modification, and in particular under the stable unit treatment value assump-
tion (SUTVA (Cox, 1958) – this states that the effect on the outcome of modifying
the risk factor should be the same for all possible interventions on the risk factor, also
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expressed as “no multiple versions of treatment” (VanderWeele and Herna´n, 2013)),
the causal estimates from different instrumental variables should target the same
causal parameter. However, in reality, taking the context of the motivating exam-
ple, different interventions on age at menopause (such as ooectomy, hysterectomy,
and hormone therapy) may have different effects on triglyceride levels; similar het-
erogeneity is expected for genetic variants that affect age at menopause via different
biological pathways. By allowing for heterogeneity in causal estimates from different
genetic variants, the notion of a single causal effect of the risk factor on the out-
come is lost, and it is not clear for what intervention on the risk factor the causal
estimate is targeting. Additionally, if the choice of genetic variants changes, then the
causal parameter also changes, as the random-effects distribution is taken across a
different set of variants. The random-effects estimate is correctly interpreted not as
targeting a common causal effect, but as targeting the average value of the distri-
bution of causal effects identified by the different variants (Riley et al., 2011). This
subtlety is not unique to causal estimation, rather it is relevant in meta-analysis more
widely (Higgins, Thompson and Spiegelhalter, 2009). However, heterogeneity is more
forgiveable in meta-analysis; it could be argued that any deviation from homogeneity
should be interpreted as evidence that the instrumental variable assumptions are vi-
olated for at least one of the genetic variants, and so a causal estimate based on all
the genetic variants should not be presented.
We take a practical approach, and view these theoretical concerns as secondary to
the primary concern of obtaining reliable causal inferences (Burgess, Butterworth and Thompson,
2015). Our view is that a literal interpretation of causal effect estimates fromMendelian
randomization is rarely justified, due to differences between the way in which genetic
variants influence the risk factor and any potential clinical intervention on the risk
factor in practice (Burgess et al., 2012). However, if there is substantial heterogeneity,
or if there are individual genetic variants that clear outliers, then the overall causal
estimate is likely to be unreliable even as a test of causality, and the instrumen-
tal variable assumptions should be examined carefully, particularly for the outlying
variants.
5.5. Conclusion. In conclusion, in a Mendelian randomization analysis using sum-
marized data in a (strict) two-sample setting (that is, when there is no overlap be-
tween the datasets in which associations with the risk factor and with the outcome
are estimated), the inverse-variance weighted method with first-order weights may
be preferred, although a random-effects model for combining the causal effects from
the individual genetic variants should be used. In a one-sample setting, or if there
is any overlap between the datasets, then a random-effects model using the second-
order weights should be preferred to avoid false-positive findings. If the overlap is
not substantial, then an analysis using the first-order weights may be presented as a
sensitivity analysis, as it may have increased power to detect a causal effect.
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Appendix.
A.1. Data for motivating example: causal effect of early menopause on triglycerides.
Information on the genetic variants included in the motivating analysis are presented
in Appendix Table A1: for each variant, we provide the rsid, nearest gene(s), ef-
fect allele, other allele, association with early menopause (expressed as number of
years earlier menopause) and standard error, and association with triglycerides (in
standard deviation units) and standard error. Associations are also displayed visu-
ally as a scatter plot in Appendix Figure A1. Associations with early menopause
are obtained from Day et al. (Day et al., 2015); larger numbers indicate that indi-
viduals with copies of the effect allele have earlier menopause on average compared
with carriers of the other allele. These association estimates are available from down-
load as part of the Supplementary Material to Day et al. (Supplementary Table 3).
Associations with triglycerides are obtained from the Global Lipids Genetics Consor-
tium (The Global Lipids Genetics Consortium, 2013), and can be downloaded from
http://csg.sph.umich.edu//abecasis/public/lipids2013/.
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Appendix Figure A1. Scatter plot of genetic associations with triglycerides (standard deviation
units) against genetic associations with early menopause (in years).
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Genetic Gene Effect Other Early menopause Triglycerides
variant region allele allele in years (SE) SD difference (SE)
rs10734411 EIF3M G A 0.12 (0.02) 0.0017 (0.0047)
rs10852344 GSPT1/BCAR4 T C 0.16 (0.02) -0.0030 (0.0047)
rs10905065 FBXO18 A G 0.11 (0.02) -0.0056 (0.0047)
rs10957156 CHD7 G A 0.14 (0.02) 0.0114 (0.0056)
rs11031006 FSHB G A 0.25 (0.03) -0.0186 (0.0068)
rs11668344 BRSK1/NLRP11/U2AF2 A G 0.41 (0.02) 0.0009 (0.0049)
rs11738223 SH3PXD2B G A 0.12 (0.02) 0.0007 (0.0036)
rs1183272 HELB T C 0.31 (0.03) 0.0005 (0.0047)
rs12142240 RAD54L C T 0.13 (0.02) 0.0051 (0.0050)
rs12196873 REV3L A C 0.16 (0.03) -0.0099 (0.0068)
rs12461110 BRSK1/NLRP11/U2AF2 G A 0.15 (0.02) 0.0061 (0.0051)
rs12824058 PIWIL1 A G 0.14 (0.02) 0.0006 (0.0048)
rs13040088 SLCO4A1/DIDO1 A G 0.16 (0.02) 0.0004 (0.0057)
rs1411478 STX6 A G 0.13 (0.02) -0.0004 (0.0047)
rs16858210 PARL/POLR2H A G 0.14 (0.02) 0.0023 (0.0055)
rs16991615 MCM8 A G 0.88 (0.04) 0.0025 (0.0073)
rs1713460 APEX1/PARP2/PNP A G 0.14 (0.02) 0.0015 (0.0056)
rs1799949 BRCA1 A G 0.14 (0.02) 0.0107 (0.0049)
rs1800932 MSH6 G A 0.17 (0.03) 0.0020 (0.0060)
rs2230365 MSH5/HLA T C 0.16 (0.03) 0.0202 (0.0046)
rs2236553 SLCO4A1/DIDO1 C T 0.16 (0.03) -0.0021 (0.0065)
rs2241584 UIMC1 A G 0.14 (0.02) -0.0007 (0.0048)
rs2277339 PRIM1/TAC3 G T 0.31 (0.03) -0.0072 (0.0080)
rs2720044 STAR C A 0.29 (0.03) 0.0043 (0.0078)
rs2941505 STARD3/PGAP3/CDK12 A G 0.13 (0.02) -0.0074 (0.0035)
rs349306 POLR2E/KISS1R G A 0.23 (0.04) -0.0082 (0.0055)
rs365132 UIMC1 G T 0.24 (0.02) -0.0003 (0.0047)
rs3741604 HELB T C 0.29 (0.03) -0.0014 (0.0047)
rs4246511 RHBDL2/MYCBP T C 0.22 (0.02) 0.0093 (0.0056)
rs427394 PAPD7 G A 0.13 (0.02) -0.0013 (0.0048)
rs451417 MCM8 C A 0.20 (0.03) 0.0019 (0.0081)
rs4693089 HELQ/FAM175A G A 0.20 (0.02) 0.0045 (0.0048)
rs4879656 APTX C A 0.12 (0.02) 0.0033 (0.0049)
rs4886238 TDRD3 A G 0.18 (0.02) 0.0009 (0.0050)
rs551087 SPPL3/SRSF9 A G 0.13 (0.02) 0.0032 (0.0036)
rs5762534 CHEK2 C T 0.16 (0.03) 0.0056 (0.0066)
rs6484478 FSHB G A 0.14 (0.02) -0.0102 (0.0053)
rs6856693 ASCL1/MLF1IP A G 0.16 (0.02) -0.0044 (0.0048)
rs6899676 SYCP2L/MAK G A 0.21 (0.03) 0.0045 (0.0058)
rs704795 BRE/GTF3C2/EIFB4 G A 0.16 (0.02) 0.0567 (0.0034)
rs707938 MSH5/HLA A G 0.16 (0.02) 0.0014 (0.0049)
rs7259376 ZNF729 A G 0.11 (0.02) -0.0041 (0.0047)
rs763121 DMC1/DDX17 G A 0.16 (0.02) -0.0179 (0.0036)
rs8070740 RPAIN G A 0.15 (0.02) 0.0121 (0.0056)
rs9039 C16orf72/ABAT C T 0.12 (0.02) -0.0068 (0.0037)
rs930036 TLK1/GAD1 A G 0.19 (0.02) -0.0001 (0.0049)
rs9393800 SYCP2L/MAK A G 0.14 (0.02) 0.0073 (0.0054)
Appendix Table A1
List of genetic variants and associations (standard errors, SE) with early menopause (years) and
with triglycerides (standard deviation, SD, difference) used in motivating example.
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A.2. Code for implementing methods used in simulation study. Code for perform-
ing the methods used in the simulation study for the R software package is provided
below:
alpx=NULL; alpxsd=NULL # genetic associations with risk factor and standard errors
alpy=NULL; alpysd=NULL # genetic associations with outcome and standard errors
for (j in 1:vars) {
alpx[j] = lm(x~g[,j])$coef[2]
alpy[j] = lm(y~g[,j])$coef[2]
alpxsd[j] = summary(lm(x~g[,j]))$coef[2,2]
alpysd[j] = summary(lm(y~g[,j]))$coef[2,2]
}
reg.first = summary(lm(alpy~alpx-1, weights=alpysd^-2))
betafirst.fixed = reg.first$coef[1] # estimate using first-order weights, fixed-effect model
betafirst.mulran = reg.first$coef[1] # estimate using first-order weights, multiplicative random-effects
sefirst.fixed = reg.first$coef[1,2]/reg.first$sigma
# standard error using first-order weights, fixed-effect model
sefirst.mulran = reg.first$coef[1,2]/min(reg.first$sigma,1)
betafirst.addran = metagen(alpy/alpx, abs(alpysd/alpx))$TE.random
# estimate using first-order weights, additive random-effects model
sefirst.addran = metagen(alpy/alpx, abs(alpysd/alpx))$seTE.random
reg.second = summary(lm(alpy~alpx-1, weights=(alpysd^2+alpy^2*alpxsd^2/alpx^2)^-1))
betasecond.fixed = reg.second$coef[1] # estimate using second-order weights, fixed-effect model
betasecond.mulran = reg.second$coef[1]
sesecond.fixed = reg.second$coef[1,2]/reg.second$sigma
sesecond.mulran = reg.second$coef[1,2]/min(reg.second$sigma,1)
betasecond.addran = metagen(alpy/alpx, sqrt(alpysd^2/alpx^2+alpy^2*alpxsd^2/alpx^4))$TE.random
sesecond.addran = metagen(alpy/alpx, sqrt(alpysd^2/alpx^2+alpy^2*alpxsd^2/alpx^4))$seTE.random
theta = 0.1 # correlation term from equation (1)
reg.second.theta = summary(lm(alpy~alpx-1,
weights=(alpysd^2+alpy^2*alpxsd^2/alpx^2-2*theta*alpy*alpxsd*alpysd/alpx)^-1))
betasecond.theta.fixed = reg.second.theta$coef[1]
# estimate using second-order weights with correlation, fixed-effect model
betasecond.theta.mulran = reg.second.theta$coef[1]
sesecond.theta.fixed = reg.second.theta$coef[1,2]/reg.second.theta$sigma
sesecond.theta.mulran = reg.second.theta$coef[1,2]/min(reg.second.theta$sigma,1)
betasecond.theta.addran = metagen(alpy/alpx,
sqrt(alpysd^2/alpx^2+alpy^2*alpxsd^2/alpx^4-2*theta*alpy*alpxsd*alpysd/alpx^3))$TE.random
sesecond.theta.addran = metagen(alpy/alpx,
sqrt(alpysd^2/alpx^2+alpy^2*alpxsd^2/alpx^4-2*theta*alpy*alpxsd*alpysd/alpx^3))$seTE.random
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A.3. Sensitivity analysis for value of θ in motivating example. As stated in Sec-
tion 5.3, in this paper we have assumed that the correlation parameter θ in the
second-order expression for the variance of a causal estimate from the delta method
(equation 2) is zero. While computational and practical considerations (the length
of the simulation study to run, and the difficulty in estimating the parameter using
summarized data only) preclude an investigation into the impact of this term in the
simulation study, we can conduct a sensitivity analysis to consider the impact of the
value of θ on estimates from the motivating example.
We conduct inverse-variance weighted analyses using weights derived from equa-
tion (2) and fixed-effect, additive random-effects, and multiplicative random-effects
models for θ = −0.2,−0.1, 0, 0.1, 0.2, 0.3. The causal estimates and 95% confidence
intervals from each analysis are presented in Appendix Table A2. We see that the
estimates and confidence intervals do not change substantially despite the wide range
of values of θ considered.
The true value of θ should be zero if the associations with the risk factor and
outcome are estimated in non-overlapping samples, and similar to the correlation
between the risk factor and the outcome if the associations are estimated in the same
individuals. With partial overlap, the value of θ will be between these two values.
Fixed-effects Additive random-effects Multiplicative random-effects
θ Estimate 95% CI Estimate 95% CI Estimate 95% CI
−0.2 0.000 -0.007, 0.007 0.004 -0.010, 0.017 0.000 -0.012, 0.012
−0.1 0.001 -0.006, 0.008 0.005 -0.009, 0.018 0.001 -0.011, 0.013
0 0.002 -0.005, 0.009 0.006 -0.008, 0.019 0.002 -0.010, 0.014
0.1 0.003 -0.004, 0.011 0.007 -0.007, 0.020 0.003 -0.009, 0.016
0.2 0.004 -0.003, 0.012 0.008 -0.006, 0.022 0.004 -0.008, 0.017
0.3 0.005 -0.002, 0.013 0.009 -0.006, 0.023 0.005 -0.008, 0.018
Appendix Table A2
Estimates and 95% confidence intervals (CI) from inverse-variance weighted analyses using
second-order weights from equation (2) with different values of the correlation parameter θ.
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A.4. Additional results from simulation study. Additional results from scenarios 1
and 2 are presented in Appendix Table A3, and from scenarios 3 and 4 in Appendix
Table A4. For each value of the instrument strength, the (Monte Carlo) standard
deviation and the mean standard error of estimates are presented. Using second-order
weights, only results from the fixed-effect analyses are presented, as heterogeneity was
not detected in the vast majority of datasets, and so results were the same up to 3
decimal places in almost all cases.
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Second-order First-order weights
Fixed-effect Fixed-effect Additive random-effects Multiplicative random-effects
α SD Mean SE SD Mean SE SD Mean SE SD Mean SE
Scenario 1. One-sample setting, valid instrumental variables
1a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 0.117 0.163 0.140 0.147 0.142 0.159 0.140 0.153
0.05 0.093 0.121 0.107 0.113 0.110 0.122 0.107 0.118
0.08 0.067 0.080 0.076 0.077 0.078 0.082 0.076 0.081
0.10 0.056 0.065 0.062 0.063 0.064 0.067 0.062 0.066
1b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 0.119 0.165 0.141 0.149 0.144 0.160 0.141 0.155
0.05 0.091 0.120 0.106 0.112 0.108 0.121 0.106 0.117
0.08 0.067 0.080 0.075 0.077 0.077 0.083 0.075 0.081
0.10 0.056 0.065 0.062 0.063 0.063 0.067 0.062 0.066
1c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 0.122 0.185 0.140 0.165 0.141 0.169 0.140 0.167
0.05 0.096 0.137 0.107 0.125 0.108 0.129 0.107 0.127
0.08 0.069 0.093 0.075 0.088 0.076 0.090 0.075 0.089
0.10 0.059 0.072 0.063 0.069 0.064 0.071 0.063 0.070
1d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 0.115 0.150 0.140 0.136 0.145 0.157 0.140 0.146
0.05 0.088 0.107 0.105 0.099 0.110 0.115 0.105 0.109
0.08 0.066 0.075 0.075 0.071 0.078 0.082 0.075 0.079
0.10 0.056 0.063 0.063 0.060 0.066 0.069 0.063 0.067
Scenario 2. One-sample setting, invalid instrumental variables
2a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 0.136 0.167 0.170 0.147 0.183 0.192 0.170 0.171
0.05 0.106 0.121 0.128 0.110 0.137 0.143 0.128 0.130
0.08 0.079 0.084 0.092 0.079 0.098 0.100 0.092 0.094
0.10 0.067 0.067 0.076 0.064 0.080 0.080 0.076 0.077
2b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 0.136 0.166 0.169 0.147 0.182 0.193 0.169 0.172
0.05 0.108 0.120 0.130 0.110 0.139 0.142 0.130 0.130
0.08 0.078 0.081 0.091 0.077 0.096 0.096 0.091 0.091
0.10 0.067 0.068 0.076 0.065 0.080 0.080 0.076 0.077
2c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 0.144 0.188 0.172 0.164 0.179 0.192 0.172 0.178
0.05 0.111 0.136 0.129 0.123 0.134 0.143 0.129 0.135
0.08 0.083 0.095 0.093 0.088 0.096 0.101 0.093 0.097
0.10 0.069 0.077 0.076 0.072 0.078 0.082 0.076 0.080
2d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 0.134 0.153 0.172 0.135 0.191 0.198 0.172 0.170
0.05 0.106 0.114 0.131 0.103 0.144 0.148 0.131 0.132
0.08 0.077 0.075 0.091 0.070 0.098 0.097 0.091 0.091
0.10 0.065 0.060 0.074 0.057 0.079 0.077 0.074 0.073
Appendix Table A3
Further simulation study results for scenarios 1 and 2 (one-sample setting, valid and invalid
instrumental variables): standard deviation (SD) of estimates and mean standard error (SE)
for various inverse-variance weighted methods with four sets of parameter values (null and
positive causal effect, positive and negative confounding) for different strengths of instrument
(α).
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Second-order First-order weights
Fixed-effect Fixed-effect Additive random-effects Multiplicative random-effects
α SD Mean SE SD Mean SE SD Mean SE SD Mean SE
Scenario 3. Two-sample setting, valid instrumental variables
3a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 0.123 0.162 0.150 0.148 0.154 0.165 0.150 0.156
0.05 0.093 0.117 0.108 0.109 0.110 0.120 0.108 0.116
0.08 0.067 0.079 0.076 0.076 0.076 0.082 0.076 0.081
0.10 0.057 0.066 0.063 0.064 0.063 0.069 0.063 0.067
3b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 0.124 0.163 0.150 0.148 0.154 0.167 0.150 0.157
0.05 0.095 0.118 0.111 0.111 0.113 0.122 0.111 0.117
0.08 0.069 0.082 0.078 0.078 0.079 0.085 0.078 0.083
0.10 0.059 0.067 0.065 0.064 0.066 0.069 0.065 0.068
3c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 0.138 0.182 0.168 0.165 0.173 0.185 0.168 0.175
0.05 0.108 0.135 0.127 0.125 0.130 0.139 0.127 0.133
0.08 0.080 0.093 0.090 0.088 0.091 0.096 0.090 0.094
0.10 0.065 0.073 0.071 0.070 0.072 0.076 0.071 0.075
3d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 0.113 0.149 0.140 0.135 0.144 0.153 0.140 0.144
0.05 0.089 0.111 0.104 0.102 0.106 0.115 0.104 0.109
0.08 0.065 0.076 0.073 0.072 0.074 0.079 0.073 0.077
0.10 0.054 0.061 0.059 0.058 0.060 0.063 0.059 0.062
Scenario 4. Two-sample setting, invalid instrumental variables
4a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 0.144 0.166 0.180 0.147 0.193 0.202 0.180 0.177
0.05 0.108 0.121 0.131 0.111 0.138 0.147 0.131 0.133
0.08 0.081 0.083 0.094 0.078 0.098 0.100 0.094 0.094
0.10 0.065 0.064 0.074 0.062 0.076 0.077 0.074 0.074
4b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 0.143 0.169 0.181 0.150 0.196 0.204 0.181 0.180
0.05 0.110 0.121 0.134 0.111 0.141 0.147 0.134 0.133
0.08 0.080 0.083 0.094 0.078 0.097 0.099 0.094 0.094
0.10 0.068 0.066 0.077 0.063 0.079 0.079 0.077 0.076
4c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 0.156 0.184 0.194 0.164 0.209 0.217 0.194 0.193
0.05 0.121 0.136 0.146 0.124 0.154 0.160 0.146 0.146
0.08 0.087 0.092 0.101 0.086 0.105 0.107 0.101 0.102
0.10 0.073 0.074 0.083 0.070 0.085 0.086 0.083 0.083
4d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 0.135 0.154 0.172 0.135 0.188 0.193 0.172 0.168
0.05 0.105 0.112 0.128 0.102 0.136 0.141 0.128 0.127
0.08 0.074 0.074 0.087 0.069 0.091 0.092 0.087 0.086
0.10 0.063 0.061 0.072 0.058 0.074 0.075 0.072 0.072
Appendix Table A4
Further simulation study results for scenarios 3 and 4 (two-sample setting, valid and invalid
instrumental variables): standard deviation (SD) of estimates and mean standard error (SE)
for various inverse-variance weighted methods with four sets of parameter values (null and
positive causal effect, positive and negative confounding) for different strengths of instrument
(α).
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A.5. Additional simulation with directional pleiotropy. To provide some guidance
as to the performance of the inverse-variance weighted method when there is direc-
tional pleiotropy, we perform a further simulation under this scenario. The parameters
and scenarios are taken to be the same as those in the main body of the paper, except
that rather than drawing the genetic effects on the risk factor (αj) and the direct
effects of the genetic variants on the outcome (βZj) from independent normal distri-
butions as in Scenarios 2 and 4, we draw them from a bivariate normal distribution.
The univariate distributions of these parameters are the same (the αj parameters have
mean α and variance 0.022; the βZj parameters have mean 0 and variance 0.02
2), but
the correlation between the distributions is set to 0.4.(
αj
βZj
)
∼ N2
(( α
0
)
,
(
0.022 0.4× 0.022
0.4 × 0.022 0.022
))
This correlation means that the direct effects of genetic variants on the outcome are
greater for those variants that have stronger effects on the risk factor, and so for those
variants that receive more weight in the analysis. Hence, although the overall mean
pleiotropic effect has mean zero, pleiotropic effects of weak and strong instruments
separately do not have mean zero. We refer to the one-sample setting with directional
pleiotropy as Scenario 6, and the two-sample setting with directional pleiotropy as
Scenario 7.
Results for the mean estimate and empirical power to detect a causal effect are
given in Appendix Table A5. In the one-sample setting (scenario 6), there is bias in
the direction of confounding in all cases. While Type 1 error rates under the null are
inflated throughout, there is a clear preference for the use of second-order weights
and random-effects models, as well as a slight preference for the additive random-
effects model (based on slightly more conservative coverage properties with first-order
weights). This mirrors the advice in the main paper. In the two-sample setting (sce-
nario 7), bias under the null is in the positive direction, whereas bias under the alterna-
tive is towards the null. Type 1 error rates under the null with random-effects models
are close to nominal levels, with conservative coverage for second-order weights, and
slightly anti-conservative coverage for first-order weights. However, the advice from
the main paper to use first-order weights in a two-sample setting would not lead to
overly misleading inferences, as Type 1 error rates with first-order weights are close
to the nominal 5% level. Power to detect a causal effect is greater using first-order
weights in this case. Hence, on the basis of these simulations, the advice in the main
body of the paper also holds with directional pleiotropy.
In practice, we repeat that estimates from the inverse-variance weighted method
will typically be biased if the genetic variants are not valid instruments (and the
example of directional pleiotropy considered here is far from extreme), and recommend
the use of robust methods (such as the Egger method and median-based methods
introduced in the discussion of the paper) as sensitivity analyses for applied Mendelian
randomization investigations.
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Fixed-effect Additive random-effects Multiplicative random-effects
Second-order First-order Second-order First-order Second-order First-order
α F R2 Mean Power Mean Power Mean Power Mean Power Mean Power Mean Power
Scenario 6. One-sample setting, invalid instrumental variables with directional pleiotropy
6a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.218 22.1 0.275 48.4 0.218 22.1 0.262 32.3 0.218 22.1 0.275 39.7
0.05 4.2 1.7% 0.142 20.1 0.152 32.3 0.142 20.0 0.123 17.4 0.142 20.1 0.152 23.9
0.08 8.6 3.3% 0.080 16.0 0.073 20.6 0.078 14.6 0.044 10.0 0.080 15.2 0.073 13.9
0.10 12.5 4.8% 0.056 14.8 0.048 18.1 0.051 11.7 0.025 8.9 0.056 12.9 0.048 11.7
6b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% -0.098 5.7 -0.125 19.2 -0.098 5.7 -0.118 10.1 -0.098 5.7 -0.125 12.8
0.05 4.2 1.7% -0.069 6.5 -0.076 15.6 -0.069 6.4 -0.060 7.2 -0.069 6.4 -0.076 9.5
0.08 8.6 3.3% -0.038 6.8 -0.034 12.8 -0.036 6.2 -0.019 6.1 -0.038 6.4 -0.034 7.6
0.10 12.5 4.8% -0.027 6.3 -0.024 10.5 -0.024 5.2 -0.012 5.4 -0.027 5.5 -0.024 6.3
6c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.380 55.6 0.471 81.6 0.380 55.6 0.465 73.3 0.380 55.6 0.471 78.4
0.05 4.2 1.7% 0.309 66.2 0.351 80.2 0.309 66.1 0.334 67.8 0.309 66.1 0.351 75.8
0.08 8.6 3.3% 0.255 81.3 0.275 86.4 0.255 80.7 0.257 74.5 0.255 81.1 0.275 82.5
0.10 12.5 4.8% 0.232 89.2 0.247 91.7 0.230 87.5 0.232 82.4 0.232 88.6 0.247 88.5
6d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% 0.047 3.5 0.073 16.4 0.047 3.5 0.083 7.0 0.047 3.5 0.073 8.2
0.05 4.2 1.7% 0.086 10.4 0.126 28.8 0.086 10.3 0.146 16.1 0.086 10.3 0.126 17.0
0.08 8.6 3.4% 0.130 42.6 0.168 63.6 0.134 40.2 0.186 49.6 0.130 39.8 0.168 47.1
0.10 12.5 4.8% 0.144 64.3 0.177 79.9 0.151 60.0 0.193 69.0 0.144 58.1 0.177 64.6
Scenario 7. Two-sample setting, invalid instrumental variables with directional pleiotropy
7a. Null causal effect (βX = 0), positive confounding (βU = +1).
0.03 2.4 1.0% 0.056 3.1 0.074 13.1 0.056 3.1 0.071 6.1 0.056 3.1 0.074 8.0
0.05 4.2 1.7% 0.037 4.0 0.041 11.6 0.037 4.0 0.032 5.2 0.037 4.0 0.041 6.6
0.08 8.6 3.3% 0.022 5.3 0.020 11.8 0.021 4.8 0.012 5.8 0.022 4.9 0.020 6.7
0.10 12.5 4.8% 0.017 5.6 0.014 10.5 0.015 4.6 0.007 5.4 0.017 4.8 0.014 6.1
7b. Null causal effect (βX = 0), negative confounding (βU = −1).
0.03 2.4 1.0% 0.056 2.7 0.072 13.0 0.056 2.7 0.068 6.0 0.056 2.7 0.072 7.5
0.05 4.3 1.7% 0.037 3.9 0.040 12.5 0.037 3.9 0.032 5.5 0.037 3.9 0.040 7.1
0.08 8.6 3.3% 0.022 5.1 0.020 11.1 0.021 4.7 0.012 5.6 0.022 4.8 0.020 6.5
0.10 12.5 4.8% 0.017 5.8 0.015 11.0 0.016 5.0 0.008 5.8 0.017 5.2 0.015 6.4
7c. Positive causal effect (βX = +0.2), positive confounding (βU = +1).
0.03 2.4 1.0% 0.141 7.6 0.192 26.5 0.141 7.6 0.193 15.1 0.141 7.6 0.192 18.3
0.05 4.2 1.7% 0.159 19.7 0.203 40.5 0.159 19.6 0.204 26.5 0.159 19.6 0.203 29.9
0.08 8.6 3.3% 0.164 43.4 0.196 61.1 0.165 41.6 0.197 46.3 0.164 41.9 0.196 49.2
0.10 12.5 4.8% 0.171 63.9 0.197 76.7 0.173 60.1 0.199 63.3 0.171 60.5 0.197 65.7
7d. Positive causal effect (βX = +0.2), negative confounding (βU = −1).
0.03 2.4 1.0% 0.137 11.1 0.189 34.4 0.137 11.1 0.188 17.7 0.137 11.1 0.189 22.0
0.05 4.2 1.7% 0.150 24.9 0.196 48.9 0.150 24.7 0.197 30.0 0.150 24.7 0.196 35.0
0.08 8.6 3.3% 0.161 56.9 0.195 73.8 0.163 53.5 0.196 56.0 0.161 54.0 0.195 59.6
0.10 12.5 4.7% 0.169 75.5 0.198 86.5 0.171 70.4 0.200 72.3 0.169 70.7 0.198 75.2
Appendix Table A5
Simulation study results for scenarios 6 and 7 (invalid instrumental variables with
directional pleiotropy, one-sample and two-sample settings): mean estimate and power (%)
of 95% confidence interval for various inverse-variance weighted methods with four sets of
parameter values (null and positive causal effect, positive and negative confounding. The
strength of the genetic variants as instruments is indicated: mean per allele effect on the risk
factor (α), mean F statistic (F ) and mean coefficient of determination (R2) from regression
of risk factor on the genetic variants.
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